XARELTO® (rivaroxaban) for Reducing the Risk of Stroke and Systemic Embolism in Patients
With Nonvalvular Atrial Fibrillation (AF) and for the Treatment of Deep Vein Thrombosis
(DVT) and Pulmonary Embolism (PE)
Sohail Jalal, M.D.
Cardiac Electrophysiologist
Dr. Sohail Jalal, M.D., earned his medical degree at King Edward Medical College in Lahore,
Pakistan and received his post-doctoral training as a house physician and surgeon from May
Hospital also in Lahore, Pakistan. He completed his internship in internal medicine at Cook
County Hospital in Chicago, Illinois, and residency in internal medicine at the University of
Missouri in Kansas City, Missouri. He then completed a fellowship in cardiology and
electrophysiology at the University of Colorado Health Science Center in Denver, Colorado,
followed by a fellowship in electrophysiology at Case Western University in Cleveland, Ohio.
Board certified by the American Board of Internal Medicine, American Board of Cardiovascular
Diseases and the American Board of Clinical Electrophysiology, Dr. Jalal has clinical interests in
arrhythmias, atrial fibrillation, cardiovascular diseases and electrophysiology.
Dr. Jalal believes in the importance of a strong patient-physician relationship. He provides
individual treatment plans, the latest in electrophysiology and diagnostic services and acts as an
advocate for his patients while providing support to the patient’s cardiologist and primary care
Dr. Jalal has served as a teacher of cardiology and a director of an interventional
electrophysiology lab. He has authored numerous medical publications and is a member of the
Houston Electrophysiology Society, Harris County Medical Society, Texas Medical Association,
American Medical Association and American Heart Association.

XARELTO - Janssen Lunch Speaker Bio